Adaptive Biotechnologies (ADPT) Net Cash Flow Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) Net Cash Flow Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | -10.07% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | -6.97% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 144.76% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 29.81% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 41.14% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -26.81% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 14.18% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 4.49% |
| 10 | Adaptive Biotechnologies | 3.48 Bn | 3.27 Bn | 52.17 Mn | 16.46% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.46% |
| Dec 31, 2025 | 28.49% |
| Sep 30, 2025 | -56.22% |
| Jun 30, 2025 | 42.01% |
| Mar 31, 2025 | 28.17% |
| Dec 31, 2024 | -16.35% |
| Sep 30, 2024 | 29.40% |
| Jun 30, 2024 | -45.48% |
| Mar 31, 2024 | -50.20% |
| Dec 31, 2023 | 60.15% |
| Sep 30, 2023 | -29.19% |
| Jun 30, 2023 | -53.62% |
| Mar 31, 2023 | -66.16% |
| Dec 31, 2022 | -99.13% |
| Sep 30, 2022 | 70.33% |
| Jun 30, 2022 | 15.19% |
| Mar 31, 2022 | -34.39% |
| Dec 31, 2021 | -9.52% |
| Sep 30, 2021 | -111.87% |